Filtriraj po Last updated date SelectPoznejePredFrom - To Date Končni datum This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Rezultati (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends approval of first vaccine for meningitis B 16 November 2012Press releaseCorporateMedicines World Diabetes Day: 14 November 2012 13 November 2012NewsCorporate Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 6-8 November 2012 9 November 2012Press releaseVeterinary European Medicines Agency increases transparency of ongoing applications for human medicines 7 November 2012NewsHumanMedicinesPharmacovigilance Fee-related incentives for advanced-therapy medicines to expire on 30 December 2012 6 November 2012NewsCorporateAdvanced therapies Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29-31 October 2012 31 Oktober 2012NewsHumanPharmacovigilance Changes to variation rules start to apply from 2 November 2012 31 Oktober 2012NewsCorporate European Medicines Agency closed 1-2 November 2012 30 Oktober 2012NewsCorporateMedicines European Medicines Agency encourages submission of quality type-I variations by end of November 29 Oktober 2012NewsCorporateMedicines Update on seasonal-influenza vaccines produced by Novartis Vaccines 26 Oktober 2012Press releaseCorporateVaccines 1 … 240 241 242 243 244 Page 244 of 384 245 246 247 248 … 384
European Medicines Agency recommends approval of first vaccine for meningitis B 16 November 2012Press releaseCorporateMedicines
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 6-8 November 2012 9 November 2012Press releaseVeterinary
European Medicines Agency increases transparency of ongoing applications for human medicines 7 November 2012NewsHumanMedicinesPharmacovigilance
Fee-related incentives for advanced-therapy medicines to expire on 30 December 2012 6 November 2012NewsCorporateAdvanced therapies
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29-31 October 2012 31 Oktober 2012NewsHumanPharmacovigilance
European Medicines Agency encourages submission of quality type-I variations by end of November 29 Oktober 2012NewsCorporateMedicines
Update on seasonal-influenza vaccines produced by Novartis Vaccines 26 Oktober 2012Press releaseCorporateVaccines